Pegcetacoplan

Empaveli, Syfovre

Complement Inhibitor

NADAC/unit N/A

No Shortage Tier 1: 0.9% PA Req: 8.5%

Pegcetacoplan blocks complement system activation to treat rare blood and immune disorders.

Covered Lives

Generic Manufacturers

APELLIS PHARMACEUTICALS INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Pegcetacoplan drfinder.aiFind doctors who prescribe Pegcetacoplan rxpbm.aiPBM spread analysis for Pegcetacoplan clinicalrx.aiClinical profile: Pegcetacoplan

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.